Dibutyl disulfide
General Information
Chemical name | Dibutyl disulfide |
CAS number | 629-45-8 |
Flavouring type | substances |
FL No. | 12.111 |
Mixture | No |
Purity of the named substance at least 95% unless otherwise specified | |
Reference body | JECFA |
From webgate.ec.europa.eu
Computed Descriptors
Download SDF2D Structure | |
CID | 12386 |
IUPAC Name | 1-(butyldisulfanyl)butane |
InChI | InChI=1S/C8H18S2/c1-3-5-7-9-10-8-6-4-2/h3-8H2,1-2H3 |
InChI Key | CUDSBWGCGSUXDB-UHFFFAOYSA-N |
Canonical SMILES | CCCCSSCCCC |
Molecular Formula | C8H18S2 |
Wikipedia | dibutyl disulfide |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 178.352 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 7 |
Complexity | 47.2 |
CACTVS Substructure Key Fingerprint | A A A D c e B w A A B g A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G A Q A A A A A C A C E Q A C C A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 50.6 |
Monoisotopic Mass | 178.085 |
Exact Mass | 178.085 |
XLogP3 | None |
XLogP3-AA | 3.4 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 10 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9745 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.6827 |
P-glycoprotein Substrate | Non-substrate | 0.6470 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8983 |
Non-inhibitor | 0.9427 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8387 |
Distribution | ||
Subcellular localization | Lysosome | 0.5730 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8749 |
CYP450 2D6 Substrate | Non-substrate | 0.7985 |
CYP450 3A4 Substrate | Non-substrate | 0.7409 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7222 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8158 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8636 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8177 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9081 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7298 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7775 |
Non-inhibitor | 0.8669 | |
AMES Toxicity | Non AMES toxic | 0.9541 |
Carcinogens | Carcinogens | 0.7139 |
Fish Toxicity | High FHMT | 0.9794 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9960 |
Honey Bee Toxicity | High HBT | 0.8110 |
Biodegradation | Not ready biodegradable | 0.8210 |
Acute Oral Toxicity | III | 0.7255 |
Carcinogenicity (Three-class) | Non-required | 0.6330 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -4.3343 | LogS |
Caco-2 Permeability | 1.4241 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.1885 | LD50, mol/kg |
Fish Toxicity | 0.1557 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.8278 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organosulfur compounds |
Class | Organic disulfides |
Subclass | Dialkyldisulfides |
Intermediate Tree Nodes | Not available |
Direct Parent | Dialkyldisulfides |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Dialkyldisulfide - Sulfenyl compound - Hydrocarbon derivative - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as dialkyldisulfides. These are organic compounds containing a disulfide group R-SS-R' where R and R' are both alkyl groups. |
From ClassyFire